HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis (2010)
- Authors:
- USP affiliated authors: SILVA, CELIO LOPES - FMRP ; CASTELO, ARLETE APARECIDA MARTINS COELHO - FMRP ; FACCIOLI, LUCIA HELENA - FCFRP
- Unidades: FMRP; FCFRP
- DOI: 10.1016/j.vaccine.2009.11.062
- Subjects: PARACOCCIDIOIDES (TRATAMENTO); IMUNOTERAPIA
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: publisher-specific-oa
-
ABNT
RIBEIRO, Alice M. et al. HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis. Vaccine, v. 28, n. 6, p. 1528-1534, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2009.11.062. Acesso em: 16 abr. 2024. -
APA
Ribeiro, A. M., Bocca, A. L., Amaral, A. C., Souza, A. C. C. O., Faccioli, L. H., Coelho-Castelo, A. A. M., et al. (2010). HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis. Vaccine, 28( 6), 1528-1534. doi:10.1016/j.vaccine.2009.11.062 -
NLM
Ribeiro AM, Bocca AL, Amaral AC, Souza ACCO, Faccioli LH, Coelho-Castelo AAM, Figueiredo F, Silva CL, Felipe MSS. HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis [Internet]. Vaccine. 2010 ; 28( 6): 1528-1534.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1016/j.vaccine.2009.11.062 -
Vancouver
Ribeiro AM, Bocca AL, Amaral AC, Souza ACCO, Faccioli LH, Coelho-Castelo AAM, Figueiredo F, Silva CL, Felipe MSS. HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis [Internet]. Vaccine. 2010 ; 28( 6): 1528-1534.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1016/j.vaccine.2009.11.062 - DNAhsp65 vaccine: state of the art
- "Prime-Boost" strategy using BCG and DNA-hsp65 induces Th1 pattern in murine model
- MRNA-HSP65 binding toll 7 and protects mice against experimental tuberculosis
- Evaluation of immune response and protection against tuberculosis using DNA-hsp65 vaccine delivery by liposomes
- Hsp65-DNA vaccine (pVAX-hsp65) stimulates cytokine production by human macrophages
- Immunomodulation and protection induced by DNA-hsp65 vaccination in an animal model of arthritis
- Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis
- Evaluation of immune response and protection against tuberculosis using DNA-hsp65 vaccine delivery by liposomes
- Tissue distribution of a plasmid DNA encoding Hsp65 gene is dependent on the dose administered through intramuscular delivery
- Lipossomas catiônicas como carreadores de vacina de DNA contra a tuberculose
Informações sobre o DOI: 10.1016/j.vaccine.2009.11.062 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
